Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 21 Nov 2025

Clinical features and HLA typing of immune checkpoint inhibitor-associated myasthenia gravis, myocarditis and myositis

in Cancer Immunity and Immunotherapy

Xiaoting Lin
Peng Liu
Min Jin
Guoyan Qi

Frontiers in Oncology

doi 10.3389/fonc.2025.1646231

319 views

Original Research

Published on 21 Nov 2025

Frailty trajectories and their determinants in cancer patients undergoing immunotherapy: a prospective longitudinal study

in Cancer Immunity and Immunotherapy

Wei Zhu
Juan Ji
Yiqun Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1684827

Case Report

Published on 20 Nov 2025

Sintilimab combined with chemotherapy in advanced pulmonary epithelioid hemangioendothelioma: a case report and translational insights

in Cancer Immunity and Immunotherapy

Lijun Jing
Huiyun An
Hao Yang
Liming Zhang
Tongyuan Li
Yongming Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1575039

164 views

Review

Accepted on 19 Nov 2025

OX40/OX40L: A New Target for Tumor Immunotherapy and Its Clinical Research Progress

in Cancer Immunity and Immunotherapy

Zixuan Yuan
Yutong Pan
Aihua Gong

Frontiers in Oncology

Systematic Review

Published on 19 Nov 2025

First-line immunochemotherapy for advanced NSCLC in Asian patients: a meta-analysis of phase 3 RCTs

in Cancer Immunity and Immunotherapy

Zhifang Mao
Zhiyong Zhang
Meijiao Song
Jiaqi He
Jing Zheng
Wenquan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1709348

372 views

Original Research

Published on 18 Nov 2025

First-line immune checkpoint inhibitors combined with chemotherapy in advanced large-cell neuroendocrine carcinoma of the lung: a real-world retrospective study

in Cancer Immunity and Immunotherapy

Beibei Ji
Wei Luan
Rula Sha
Wenxin Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1709544

527 views

Correction

Published on 18 Nov 2025

Correction: Case Report: Curative effect and mechanism of surufatinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma

in Cancer Immunity and Immunotherapy

Shuanglong Xiong
Chengxiang Yang
Kaiwen Fu
Xingyun Liao
Yao Ding
Kexue Zhou
Li Zhang
Yan Teng
Chunman Wu
Yongsheng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1730518

214 views

Case Report

Accepted on 17 Nov 2025

Ivonescimab for EGFR-mutant lung adenosquamous carcinoma after multiline therapy: a case report

in Cancer Immunity and Immunotherapy

Pan Xiaohua
Zhang Jianya
Ye Chao
Zhu Wanhui
Qu Wenshu

Frontiers in Oncology

124 views

Original Research

Accepted on 14 Nov 2025

A CD47 Antibody with Minimized Erythrocyte and Thrombocyte Toxicities

in Cancer Immunity and Immunotherapy

Min Pei
Xiao-Dong Dai
Xiao-Fan Jiang
Cai-Yi Yuan
Jie Tan
Kai-Feng He
Guo-Jian Liu
Jin-Di Zhu
Huan-Huan Li
Ai-Ling Pan

Frontiers in Oncology

178 views

Original Research

Published on 14 Nov 2025

Phytochemical and nanoparticle-based therapeutic potential of Sphaeranthus indicus against hepatocellular carcinoma via cryptomeridiol targeting

in Cancer Immunity and Immunotherapy

Ritika Ravindra Konduskar
Abhinandan R. Patil
Somnath D. Bhinge
Gourav Rameshlal Chawla
Yash Bhagavan Yadav

Frontiers in Oncology

doi 10.3389/fonc.2025.1691905

494 views

Mini Review

Accepted on 13 Nov 2025

Myeloid-Driven Immunosuppression in Head and Neck Cancer: Single-Cell ATAC/RNA and Spatial Transcriptomic Perspectives

in Cancer Immunity and Immunotherapy

Rui Luo
Yang Jianzheng
Zimeng Cao
Bing Li

Frontiers in Oncology

179 views

Brief Research Report

Accepted on 13 Nov 2025

Exploratory Spatial Transcriptomic Profiling of Peritumoral Th2 Immune Polarization in HPV-Positive Oropharyngeal Cancer

in Cancer Immunity and Immunotherapy

Naohiro Wakisaka
Makiko Moriyama-Kita
Satoru Kondo
Eiji Kobayashi
Takayoshi Ueno
Yosuke Nakanishi
Kazuhira Endo
Hisashi Sugimoto
Tomokazu Yoshizaki

Frontiers in Oncology

164 views

Original Research

Published on 13 Nov 2025

Adjuvant tyrosine kinase inhibitors plus anti-PD-1 therapy reduce recurrence in high-risk hepatocellular carcinoma after resection

in Cancer Immunity and Immunotherapy

Jiaxin Li
Yukun Sun
Ziniu Liu
Jianwen Huang
Jian Wu
Yun Huang
Yali Gao
Baomin Chen
Qiang He

Frontiers in Oncology

doi 10.3389/fonc.2025.1710602

1,473 views

Case Report

Accepted on 12 Nov 2025

Malignant Mesothelioma in Rare Sites: Two Case Reports

in Cancer Immunity and Immunotherapy

Qiguang Du
Jialu Guo
Zi Zhu
Yutong Zhang
He Cui
Zhongkai Xu
Rang Yang
Wenlong Liang

Frontiers in Oncology

100 views

Mini Review

Accepted on 12 Nov 2025

Immunocytokines in Cancer Immunotherapy: Opportunities and Challenges

in Cancer Immunity and Immunotherapy

Shubo Wang
Lisha Yao
Jianying Cai
Huiquan Gao
FUXIN ZHOU

Frontiers in Oncology

106 views

Case Report

Published on 12 Nov 2025

Case Report: Accelerated parathyroid adenoma progression and hypercalcemia-driven neurotoxicity following pembrolizumab-based neoadjuvant therapy in triple-negative breast cancer: a case of multisystem immune-related adverse events

in Cancer Immunity and Immunotherapy

Yi Zeng
Yu Sun
Pengfei Qian

Frontiers in Oncology

doi 10.3389/fonc.2025.1607957

395 views